Selected Publications
BraitM, MunariE, LeBron C, Noordhuis MG, Begum S, Michalidi C, Gonzalez-Roibon N, Maldonado L, Sen T, Guerrero-Preston R, Cope L, Parrella P, Fazio VM, Ha PK, Netto GJ, Sidransky D and Hoque MO. Genome-Wide Methylation Profiling and the PI3K-AKT Pathway Analysis Associated with Smoking in Urothelial Cell Carcinoma. Cell Cycle. 2013 Feb 22; 12 (7). PMID: 23435205
Zhong X, Isharwal S, Naples JM, Shiff C, Veltri RW, Shao C, Bosompem KM, Sidransky D and Hoque MO. Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. PLoS One. 2013; 8 (3):e59089.PMID: 23527093
Ostrow KL, Michalidi C, Guerrero-Preston R, Hoque MO, Greenberg A, Rom W and Sidransky D. Cigarette smoke induces methylation of thetumor suppressor gene NISCH. Epigenetics, 2013 Mar 15; 8 (4). PMID: 23503203
BraitM, Maldonado L, Noordhuis M, Begum S, Loyo M, Poeta ML, BarbosaA, FazioVM, Angioli R, Rabitti C, Marchionni L, Graeff P, Zee AGJ, Wisman GB,Sidransky D, Hoque MO. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression. PLoS One. 2013 Sep 27;8 (9):e70878. doi: 10.1371/journal.pone.0070878. PMID: 24086249
Enrico Munari, Luigi Marchionni, Apurva Chitre, Masamichi Hayashi, Guido Martignoni, Matteo Brunelli, Stefano Gobbo, Pedram Argani, Mohamad Allaf, Hoque MO, George J. Netto. Clear cell papillary renal cell carcinoma: microRNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell Carcinoma. Human Pathology 01/2014 Hum Pathol. 2014 Jun;45(6):1130-8. doi: 10.1016/j.humpath.2014.01.013. Epub 2014 Jan 31. (Corresponding author). PMID: 24703100
Maldonado L, Brait M, Loyo M, Sullenberger L, Wang K, Peskoe SB, Rosenbaum E, Howard R, Toubaji A, Albadine R, Netto GJ, Hoque MO, Platz EA, Sidransky D. GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer. J Urol. 2014 Apr 21. pii: S0022-5347(14)03413-2. doi: 10.1016/j.juro.2014.04.082. PMID: 24769028
Izumchenko EG, Chang X, Michailidi C, Kagohara LT, Ravi R, Paz K, Brait M, Hoque MO, Ling S, Bedi A, Sidransky D. The TGFβ-miR200-Mig6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors. Cancer Res. 2014 May 15. PMID: 24830724
Hayashi M, Bernert H, Kagohara LT, Maldonado L, Brait M, Schoenberg M, Bivalacqua T, Netto GJ, Koch W, Sidransky D, Hoque MO. Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine. Oncotarget. 2014 May 7. PMID: 24830820
Maldonado L, Brait M, Michailidi C, Munari E, Driscoll T, Schultz L, Bivalacqua T, Schoenberg M, Sidransky D, Netto GJ and Hoque MO. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. Oncotarget, 2014, Jun 23. PMID: 24980822
MunariM, ChauxA, Maldonado L, CompératE, BivalacquaTJ, Hoque MO, Netto GJ. Cyclin A1 Expression is Associated with Tumor Progression in pT1 Urothelial Carcinoma of Bladder: A Tissue Microarray Study of 149 Patients Treated by Transurethral Resection. Histopathology, 2014 Jul 12. doi: 10.1111/his.12499. [Epub ahead of print] PMID: 25039670 (corresponding author).
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.